Dr. Sulaiman Al Habib Medical Services Group revenue and financials
SAR 228.90Change from previous close: +0.18%Absolute change: +SAR 0.40
In the fiscal year ended December 2025, Dr. Sulaiman Al Habib Medical Services Group reported revenue of SAR 13.71B (+22.38% year over year). Net income was SAR 2.4B, a net margin of 17.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +22.38%
- 2025 vs 2024
- Net income growth
- +3.72%
- 2025 vs 2024
- Net margin
- 17.5%
- 2024: 20.7%
Financial data
Amounts in millions of SAR; per-share values in SAR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 778 | 1,055 | 1,037 | 1,169 | 463 | 734 | 1,091 | 973 | 111 | 796 | 1,178 | 946 |
| Depreciation and amortization | 221 | 213 | 185 | 172 | 163 | 152 | 133 | 113 | 92.4 | 81.9 | 78.5 | 78.1 |
| Capital expenditure | -563 | -473 | -513 | -787 | -750 | -934 | -948 | -898 | -920 | -1,062 | -791 | -1,304 |
| Investing cash flow | -563 | -540 | -513 | -774 | -750 | -934 | -898 | -904 | -911 | -1,062 | -789 | -1,306 |
| Financing cash flow | -308 | -381 | -354 | -468 | -76.6 | -142 | 322 | 966 | -388 | 176 | -220 | 372 |
| Dividends paid | -354 | -459 | -424 | -417 | -392 | -431 | -420 | -410 | -410 | -403 | -410 | -350 |
| Debt issued | 200 | 400 | 200 | 175 | 450 | 400 | 842 | 1,340 | 90.9 | 731 | 220 | 1,013 |
| Debt repaid | -50.9 | -215 | -40.2 | -144 | -53.9 | -31.7 | -31.7 | -13.9 | -46.7 | -138 | -18.8 | -273 |
| Net change in cash | -93.2 | 134 | 170 | -73.5 | -363 | -342 | 515 | 1,035 | -1,188 | -91.1 | 170 | 11.9 |
| Free cash flow | 215 | 582 | 524 | 382 | -287 | -201 | 142 | 74.8 | -809 | -267 | 388 | -358 |
| Levered free cash flow | -205 | 222 | 90.0 | -4.3 | -655 | -504 | -244 | -250 | -1,045 | -579 | 140 | -620 |